Urantide alleviates lipopolysaccharide/D-galactosamine-induced acute liver failure through upregulating carboxylesterase1f in mice
Wanhua Yang, Shu Bian, Liangming Liu · 2025
Read Urantide alleviates lipopolysaccharide/D-galactosamine-induced acute liver failure through upregulating carboxylesterase1f in mice by Wanhua Yang, Shu Bian, Liangming Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753892.txt.
Description
Wanhua Yang, Shu Bian, and Liangming Liu test, in a 2025 mouse study, whether blocking one hormone signal protects the liver from sudden failure. Acute liver failure was triggered with two toxins that mimic the human emergency. A hormone called urotensin II surged in the liver after the insult. At the same time, a detox enzyme, Ces1f, fell. The team suspected the hormone was suppressing the enzyme.
They pretreated some mice with urantide, a drug that blocks the hormone's receptor. In those mice the hormone's rise was blunted and the enzyme's fall was softened. Blood markers of liver damage dropped, and the tissue injury under the microscope looked milder. The authors conclude the hormone-enzyme link is real in this model. They propose the blocker as a candidate treatment for a condition that still kills many patients.
Catalog record
| CREATOR | Wanhua Yang, Shu Bian, Liangming Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |